Robert Azelby Insider Trading $CLVS Clovis Oncology, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Robert Azelby.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Robert Azelby. Robert Azelby is Director in IMMUNOMEDICS INC ($IMMU) and Director in Cascadian Therapeutics, Inc. ($CASC) and President and CEO in ALDER BIOPHARMACEUTICALS INC ($ALDR) and Director in Clovis Oncology, Inc. ($CLVS) and EVP & Chief Commercial Officer in Juno Therapeutics, Inc. ($JUNO) and See Remarks in Juno Therapeutics, Inc. ($JUNO).

Robert Azelby in Clovis Oncology, Inc.

Trading Symbol: CLVS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Robert Azelby: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 11 2021
$CLVS Market Capitalization: $2.45B
$CLVS Previous Close: $60.00

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Robert Azelby in Clovis Oncology, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ALDR, CASC, CLVS, IMMU, JUNO

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 11 2021CLVSClovis Oncology, I ...Azelby RobertDirectorOption ExerciseA5.9742,223252,07142,223
Jun 05 2020CLVSClovis Oncology, I ...Azelby RobertDirectorOption ExerciseA6.4840,138260,09440,138
Jun 07 2019CLVSClovis Oncology, I ...Azelby RobertDirectorOption ExerciseA14.6628,882423,41028,882
Jun 07 2019CLVSClovis Oncology, I ...Azelby RobertDirectorOption ExerciseA14.6628,882423,41028,882
Oct 15 2018CLVSClovis Oncology, I ...Azelby RobertDirectorOption ExerciseA27.9225,848721,67625,848
Oct 15 2018CLVSClovis Oncology, I ...Azelby RobertDirectorOption ExerciseA27.9225,848721,67625,848

Page:   1